Application

18157573 · Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

Filed 2023-01-20 · Granted · Patent 12076372 (2024-09-03) The official file ↗The patent and its PDF ↗ · Art unit 1654 · Examiner Kristina M Hellman Typical · CPC A61K 9/19 · BIOMARIN PHARMACEUTICAL INC. · Marshall, Gerstein & Borun LLP (Biomarin)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

5.1 mo

to disposition 19.4 mo

Statutes raised

112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.